What’s Going On with PSTX Stock? News of the acquisition has sent PSTX stock surging this morning. Shares have skyrocketed 225% since markets opened, and they are showing no signs of slowing down.

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

Poseida Therapeutics (NASDAQ:PSTX) just reported results for the second quarter of 2024. Poseida Therapeutics reported earnings per share of -32 cents. This was above the analyst estimate for EPS of ...

Poseida Therapeutics is a biopharmaceutical company specializing in cell and gene therapies for cancer and genetic conditions. The company's proprietary gene editing and delivery platforms show ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Poseida Therapeutics, Inc. (NASDAQ: PSTX) to Roche Holdings, Inc. for $9.00 per share in ...

Poseida Therapeutics is an oncology-focused biotech specializing in the development of cell therapies, particularly CAR T-cell approaches for multiple myeloma and acute leukemia. They have ...

Poseida Therapeutics (NASDAQ:PSTX) just reported results for the first quarter of 2024. Poseida Therapeutics reported earnings per share of -25 cents. This was above the analyst estimate for EPS of ...